Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1097 of 1,261
  1. US 7144867

    Anticancer glycoside compounds

    Northwestern University Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  2. US 7144986

    Polypeptides comprising IL-6 ligand binding receptor domains

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  3. US 7144900

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  4. US 7144916

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  5. US 7141434

    Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase

    Rigel Pharmaceuticals, Inc. Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  6. US 7141598

    Imidazole derivatives, production method thereof and use thereof

    Takeda Pharmaceutical Company Limited Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  7. US 7141661

    Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  8. US 7141233

    Radionuclide labeling of vitamin B12 and coenzymes thereof

    Regents of the University of Minnesota Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  9. US 7141236

    Methods and compositions for delivering macromolecules to or via the respiratory tract

    Nektar Therapeutics Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  10. US 7141238

    Compositions for reducing UV-induced inhibition of collagen biosynthesis in human skin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  11. US 7141234

    Imaging of drug accumulation as a guide to antitumor therapy

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  12. US 7141671

    Biphenyl derivatives

    Theravance, Inc. Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  13. US 7141405

    Chimeric GB virus B (GBV-B)

    The Board of Regents of the University of Texas System Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  14. US 7141553

    A3AR agonists for the treatment of inflammatory arthritis

    Can-Fite Biopharma Ltd. Israel Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  15. US 7141589

    Methods of inhibiting formation of vascular channels and methods of inhibiting proliferation

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  16. US 7141648

    Synthesis of cyclosporin analogs

    Isotechnika, Inc. Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  17. US 7141409

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  18. US 7141603

    Antitumor agents

    The Regents of the University of California Β· Granted Nov 28, 2006 Β· Expires Nov 23, 2026

    granted
  19. US 7138569

    Nucleic acids encoding pseudomonas hop proteins and use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Nov 21, 2006 Β· Expires Nov 16, 2026

    granted
  20. US 7138141

    Dispersible macromolecule compositions and methods for their preparation and use

    Nektar Therapeutics Β· Granted Nov 21, 2006 Β· Expires Nov 16, 2026

    granted
  21. US 7138249

    Screening method

    Takeda Pharmaceutical Company Limited Β· Granted Nov 21, 2006 Β· Expires Nov 16, 2026

    granted
  22. US 7138384

    Modulators of DNA cytosine-5 methyltransferase and methods for use thereof

    The Regents of the University of California Β· Granted Nov 21, 2006 Β· Expires Nov 16, 2026

    granted
  23. US 7138533

    Preventives/remedies for urinary disturbance

    Takeda Pharmaceutical Company Limited Β· Granted Nov 21, 2006 Β· Expires Nov 16, 2026

    granted
  24. US 7138237

    Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

    The Regents of the University of California Β· Granted Nov 21, 2006 Β· Expires Nov 16, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.